19
Computational Approaches to Predict Repeat-Dose Toxicity: Lessons Learned from Cosmetic Ingredients: Introduction Mark Cronin, Liverpool John Moores University, England Chihae Yang, Altamira LLC, Columbus OH

Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Computational Approaches to Predict Repeat-Dose Toxicity: Lessons Learned

from Cosmetic Ingredients: Introduction

Mark Cronin, Liverpool John Moores University, England

Chihae Yang, Altamira LLC, Columbus OH

Page 2: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Global Cosmetics Industry

• A major employer

– 1.5 million people directly and indirectly employed in the EU cosmetics industry

– More than 25,000 scientists

• EU cosmetic industry worth over €70 billion

• Many products, much innovation

– Soap, shampoo, hair dyes, toothpaste, make-up etc…

• Cosmetics give us self-confidence, well-being and sometimes even health

Page 3: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Cosmetics Ingredients Have a

Diverse Chemical Space

Page 4: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Toxicity is Not Acceptable,

But Neither is Animal Testing

• Cosmetics are a vanity product ….

• Decades of public opinion and pressure

• European Union Cosmetics Regulation

– No testing on products

– No further testing on ingredients

Page 5: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Toxicity is Not Acceptable,

But Neither is Animal Testing

• Cosmetics are a vanity product ….

• Decades of public opinion and pressure

• European Union Cosmetics Regulation

– No testing on products

– No further testing on ingredients

How are we going to ensure safety of

existing and new cosmetics ingredients?

Page 6: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Aims to derive a concentration that causes no effect

Effect(s)

Dose

50%

0%

100%

NOEL

LOEL

NOEL = No Observed

Effect Level

“Traditional” Method of Identifying Hazard:

In Vivo Repeat Dose Toxicity Testing

Page 7: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Aims to derive a concentration that causes no effect

Effect(s)

Dose

50%

0%

100%

NOEL

LOEL

NOEL = No Observed

Effect Level

“Traditional” Method of Identifying Hazard:

In Vivo Repeat Dose Toxicity Testing

Page 8: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Alternatives to In Vivo Toxicity Testing

• Biological: In vitro, molecular biology • Computational: In silico, (Q)SAR, read-across, PBPK, TTC

Page 9: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Alternatives to In Vivo Toxicity Testing

For the systemic toxicological endpoints of repeated dose toxicity, carcinogenicity and reproductive toxicity, the time

horizon for full replacement could not be estimated

• Biological: In vitro, molecular biology • Computational: In silico, (Q)SAR, read-across, PBPK, TTC

Page 10: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

European SEURAT-1 Research Initiative

Towards the replacement of in vivo repeated dose systemic toxicity testing

€ 25 million funding from both the European Commission and Cosmetics Europe, 2011-2015

Page 11: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Models For Toxic Effects:

Linking Chemistry, Modelling and Safety

Page 12: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Basis of Toxicity Prediction

Intrinsic Hazard Bioavailability

Page 13: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Basis of Toxicity Prediction

Intrinsic Hazard Bioavailability

Positive

Prediction of Effect

Page 14: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Basis of Toxicity Prediction

Intrinsic Hazard Bioavailability

Positive

Dose Required to

Achieve an Effective

Concentration

Prediction of Effect

Prediction of ADME

Page 15: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Basis of Toxicity Prediction

Intrinsic Hazard Bioavailability

Positive

Dose Required to

Achieve an Effective

Concentration

Prediction of Effect

Prediction of ADME

Exposure

Page 16: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

Basis of Toxicity Prediction

Intrinsic Hazard Bioavailability

Positive

Dose Required to

Achieve an Effective

Concentration

Prediction of Effect

Prediction of ADME

Exposure Assessment of Risk

Page 17: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

The Project

Integrated In Silico Models for the Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety

6.7 Mio EUR ◦ 14 Partners EC FP7 – Cosmetics Europe

COSMOS is an EU project developing methods for determining the safety of cosmetic ingredients for humans, without the use of animals, using computational models.

www.cosmostox.eu

Page 18: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

In Silico Models

Project

New Toxicological Databases

Threshold of Toxicological Concern (TTC)

PBPK and In Vitro – In Vivo Extrapolation

Page 19: Computational Approaches to Predict Repeat-Dose Toxicity ... · Prediction of Human Repeated Dose Toxicity of COSMetics to Optimise Safety 6.7 Mio EUR 14 Partners EC FP7 – Cosmetics

This Session:

Lessons Learnt from Cosmetics

• Databases, Tools and TTC Approach Applied To Chemicals In Cosmetics Products – Chihae Yang

• Role of Bioavailability in Risk Assessment of Cosmetic Ingredients: Kinetics, Permeation, and Metabolism – Elena Fioravanzo

• Adverse Outcome Pathways (AOPs) for Target Organ Effects: The Role of Structural Alerts and Chemotypes for Liver Toxicity to Group Compounds and Apply Read-Across – Mark Cronin

• Applying Databases and Tools from COSMOS to the Scientific Needs of US FDA’s CERES Project - Kirk Arvidson

• US EPA’s ToxCast, Tox21, and COSMOS Projects: Cheminformatics Approaches to Creating Data Linkages and Synergies – Ann Richard

• Questions and Discussion